[
  {
    "ts": null,
    "headline": "Gilead Stock Rises 8% Post Q4 Earnings: Should You Buy or Sell?",
    "summary": "GILD's strong HIV portfolio should maintain momentum for the company. The guidance for 2025 is impressive. We believe there is more room for growth and recommend the stock to investors.",
    "url": "https://finnhub.io/api/news?id=263c82875c6ea1ec9ff53ef3136ed9d477435a111266621eb1bd68f77594dfef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739817360,
      "headline": "Gilead Stock Rises 8% Post Q4 Earnings: Should You Buy or Sell?",
      "id": 132766586,
      "image": "https://media.zenfs.com/en/zacks.com/79b7ecb3a59852f0816e6eb69c31b2fe",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "GILD's strong HIV portfolio should maintain momentum for the company. The guidance for 2025 is impressive. We believe there is more room for growth and recommend the stock to investors.",
      "url": "https://finnhub.io/api/news?id=263c82875c6ea1ec9ff53ef3136ed9d477435a111266621eb1bd68f77594dfef"
    }
  },
  {
    "ts": null,
    "headline": "Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?",
    "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
    "url": "https://finnhub.io/api/news?id=2f50924c35a2ce3937ac1dff859115fd660cde578f82fd4e3769aa1629a94f77",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739803216,
      "headline": "Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?",
      "id": 132766587,
      "image": "https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
      "url": "https://finnhub.io/api/news?id=2f50924c35a2ce3937ac1dff859115fd660cde578f82fd4e3769aa1629a94f77"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc. (GILD) Hit a 52 Week High, Can the Run Continue?",
    "summary": "Gilead (GILD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
    "url": "https://finnhub.io/api/news?id=f7037a0034c24260e441542d116996a58d3656fcd85db0aac6b097b4b9b909d6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739801714,
      "headline": "Gilead Sciences, Inc. (GILD) Hit a 52 Week High, Can the Run Continue?",
      "id": 132766588,
      "image": "https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead (GILD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
      "url": "https://finnhub.io/api/news?id=f7037a0034c24260e441542d116996a58d3656fcd85db0aac6b097b4b9b909d6"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc. (GILD): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Gilead Sciences, Inc. (GILD) on Substack by Disruptive analytics. In this article, we will summarize the bulls’ thesis on GILD. Gilead Sciences, Inc. (GILD)’s share was trading at $104.08 as of Feb 14th. GILD’s trailing and forward P/E were 273.89 and 13.37 respectively according to Yahoo Finance. Gilead Sciences (GILD) […]",
    "url": "https://finnhub.io/api/news?id=c0a5d6ae8a0e0bf795293e19b1e67149f161a49241002ef8f805708abfa43bc1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739797036,
      "headline": "Gilead Sciences, Inc. (GILD): A Bull Case Theory",
      "id": 132766589,
      "image": "https://media.zenfs.com/en/insidermonkey.com/eac1823d9f28febc8d255a13ab8f3e5e",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on Gilead Sciences, Inc. (GILD) on Substack by Disruptive analytics. In this article, we will summarize the bulls’ thesis on GILD. Gilead Sciences, Inc. (GILD)’s share was trading at $104.08 as of Feb 14th. GILD’s trailing and forward P/E were 273.89 and 13.37 respectively according to Yahoo Finance. Gilead Sciences (GILD) […]",
      "url": "https://finnhub.io/api/news?id=c0a5d6ae8a0e0bf795293e19b1e67149f161a49241002ef8f805708abfa43bc1"
    }
  },
  {
    "ts": null,
    "headline": "Coca-Cola, Home Depot And Walmart Among 10 Companies To Announce Dividend Increases In Second Half Of February",
    "summary": "Februaryâs dividend increases slow, but major companies like Coca-Cola and Walmart are still raising dividends. Find out which 10 companies are increasing payouts.",
    "url": "https://finnhub.io/api/news?id=59ab27c195251cd9e5c1d7021f94f47974e74b4b8f113135e9ddea8acec9d76f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739757520,
      "headline": "Coca-Cola, Home Depot And Walmart Among 10 Companies To Announce Dividend Increases In Second Half Of February",
      "id": 132743511,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2179041715/image_2179041715.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Februaryâs dividend increases slow, but major companies like Coca-Cola and Walmart are still raising dividends. Find out which 10 companies are increasing payouts.",
      "url": "https://finnhub.io/api/news?id=59ab27c195251cd9e5c1d7021f94f47974e74b4b8f113135e9ddea8acec9d76f"
    }
  }
]